NCT02373371 2025-07-29
Actinic Keratoses Treatment With Metvix® in Combination With Light
University Hospital, Limoges
Phase 3 Completed
Clinical Trials
12 trialsNCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT00472108 2024-08-05
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma
Galderma R&D
Phase 3 Completed
NCT01966120 2023-07-28
Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT00306800 2021-02-18
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
Galderma R&D
Phase 3 Completed
NCT00907413 2015-06-03
PDT
Weill Medical College of Cornell University
Phase 3 Terminated
NCT00869635 2014-02-06
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Asan Medical Center
Phase 3 Completed
NCT00253617 2013-04-04
Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Withdrawn
NCT00926952 2011-09-09
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Innovaderm Research Inc.
Phase 3 Completed
NCT00540735 2010-02-04
CK/PDT
University Hospital, Angers
Phase 3 Terminated
NCT00308854 2008-04-11
Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK
photonamic GmbH & Co. KG
Phase 3 Completed
NCT00308867 2008-04-11
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
photonamic GmbH & Co. KG
Phase 3 Completed